Lung Cancer Diagnostics Market

The Lung Cancer Diagnostics Market is segmented by Cancer Type (Non-small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC)), Test Type (EGFR Mutation Test, HER2 Test, ALK Rearrangement Test, KRAS Mutation Test, Angiogenesis Inhibitor Test, CA Test), End User (Hospital Laboratories, Pathology Laboratories, Research & Academic Institutes, POCT Settings), and Region. Forecast for 2026 to 2036.